The EHA Research Roadmap: Malignant Myeloid Diseases

• Hartmut Döhner,
• Luca Malcovati,
• Gert J. Ossenkoppele,
• Andreas Hochhaus,
• Alessandro Maria Vannucchi,
• Lars Bullinger,
• Francisco Cervantes,
• Charles Craddock,
• Theo de Witte,
• Konstanze Döhner,
• Hervé Dombret,
• Pierre Fenaux,
• Jan Geissler,
• Ulrich Germing,
• Francois Guilhot,
• Claire Harrison,
• Eva Hellström-Lindberg,
• Francesco Passamonti,
• Jorge Sierra,
• Radek Skoda,
• Agnieszka Wierzbowska

Affiliations

Hartmut Döhner

1 Department of Internal Medicine III, Ulm University Hospital, Germany

Luca Malcovati

2 Department of Molecular Medicine, University of Pavia & Department of Hematology Oncology, IRCCS S. Matteo Hospital Foundation, Pavia, Italy

Gert J. Ossenkoppele

3 Amsterdam UMC, Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands

Andreas Hochhaus

4 Universitätsklinikum Jena, Klinik für Innere Medizin II, Hämatologie/Onkologie, Jena, Germany

Alessandro Maria Vannucchi

5 Center Research and Innovation of Myeloproliferative neoplasms, CRIMM, University of Florence, Azienda Ospedaliera-universitaria Careggi, Italy

Lars Bullinger

6 Department of Hematology, Oncology, and Tumor Immunology, Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Germany

Francisco Cervantes

7 Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Germany

Charles Craddock

8 Hospital Clínic Barcelona, Spain

Theo de Witte

9 Centre For Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom

Konstanze Döhner

1 Department of Internal Medicine III, Ulm University Hospital, Germany

Hervé Dombret

11 Institut de Recherche Saint-Louis (IRSL), Université de Paris, Hôpital Saint-Louis, Paris, France

Pierre Fenaux

12 Département (DMU) d’hématologie et immunologie, Assistance Publique Hôpitaux de Paris, Hôpital St Louis, Université de Paris, France

Jan Geissler

13 Leukemia Patient Advocates Foundation, Bern, Switzerland

Ulrich Germing

14 Klinik für Hämatologie, Onkologie und Klinische Immunologie, Universitätsklinikum Düsseldorf, Heinrich-Heine Universität Düsseldorf, Germany

Francois Guilhot

15 University of Poitiers, France

Claire Harrison

16 Department of Haematology, Guys and St Thomas’Hospital, London, United Kingdom

Eva Hellström-Lindberg

17 Center for Hematology and Regenerative Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

Francesco Passamonti

18 University of Insubria, Varese, Italy

Jorge Sierra

20 Hospital de la Santa Creu i de Sant Pau and Jose Carreras Leukemia Research Institute, Barcelona, Spain

Radek Skoda

21 Department of Biomedicine, Experimental Hematology, University Hospital Basel and University of Basel, Switzerland

Agnieszka Wierzbowska

22 Multi-specialized Center of Oncology and Traumatology, Lodz, Poland